Myota is a science and tech-based platform that develops fiber-based microbiome interventions to treat and prevent chronic disease.
Myota has raised $4.5M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Myota's investors include PeakBridge, Tekton Ventures.
Myota is headquartered in London, United Kingdom.
Myota is a science and tech-based platform that develops fiber-based microbiome interventions to treat and prevent chronic disease.
Myota is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myota — Funding & Investors." VCBacked, June 23, 2026, https://www.vcbacked.co/company/myota-london. Accessed October 21, 2026.
VCBacked. (2026). Myota — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/myota-london
{{cite web |title=Myota — Funding & Investors |url=https://www.vcbacked.co/company/myota-london |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated